Literature DB >> 17711777

Oxygen sensitivity of reporter genes: implications for preclinical imaging of tumor hypoxia.

Ivana Cecic1, Denise A Chan, Patrick D Sutphin, Pritha Ray, Sanjiv Sam Gambhir, Amato J Giaccia, Edward E Graves.   

Abstract

Reporter gene techniques have been applied toward studying the physiologic phenomena associated with tumor hypoxia, a negative prognostic indicator. The purpose of this study was to assess the potential adverse effects of hypoxic conditions on the effectiveness of four commonly used reporter genes: Renilla luciferase, monomeric red fluorescent protein, thymidine kinase, and lacZ. Tumor-forming A375 cells expressing a trifusion reporter consisting of Renilla luciferase, monomeric red fluorescent protein, and thymidine kinase were subjected to decreasing oxygen tensions and assayed for reporter expression and activity. A375 cells expressing beta-galactosidase were similarly exposed to hypoxia, with activity of the reporter monitored by cleavage of the fluorescent substrate 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one)-beta-galactoside (DDAOG). Generation of signal in in vivo tumor models expressing bioluminescent or beta-galactosidase reporters were also examined over the course of hypoxic stresses, either by tumor clamping or the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Our findings indicate that bioluminescent and fluorescent reporter activity are decreased under hypoxia despite minimal variations in protein production, whereas beta-galactosidase reporter activity per unit protein was unchanged. These results demonstrate that combining beta-galactosidase with the DDAOG optical probe may be a robust reporter system for the in vivo study of tumor hypoxia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17711777

Source DB:  PubMed          Journal:  Mol Imaging        ISSN: 1535-3508            Impact factor:   4.488


  10 in total

1.  Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI.

Authors:  Heling Zhou; Rami R Hallac; Ramona Lopez; Rebecca Denney; Matthew T MacDonough; Li Li; Li Liu; Edward E Graves; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

Review 2.  Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.

Authors:  Candice Ashmore-Harris; Madeleine Iafrate; Adeel Saleem; Gilbert O Fruhwirth
Journal:  Mol Ther       Date:  2020-03-20       Impact factor: 11.454

3.  Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases.

Authors:  Karianne G Fleten; Kine M Bakke; Gunhild M Mælandsmo; Andreas Abildgaard; Kathrine Røe Redalen; Kjersti Flatmark
Journal:  Clin Exp Metastasis       Date:  2016-11-03       Impact factor: 5.150

4.  A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level.

Authors:  Raghu Erapaneedi; Vsevolod V Belousov; Michael Schäfers; Friedemann Kiefer
Journal:  EMBO J       Date:  2015-11-23       Impact factor: 11.598

5.  High-throughput quantitative bioluminescence imaging for assessing tumor burden.

Authors:  Angelina Contero; Edmond Richer; Ana Gondim; Ralph P Mason
Journal:  Methods Mol Biol       Date:  2009

6.  Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.

Authors:  Annamaria Rapisarda; Melinda Hollingshead; Badarch Uranchimeg; Carrie A Bonomi; Suzanne D Borgel; John P Carter; Bradley Gehrs; Mark Raffeld; Robert J Kinders; Ralph Parchment; Miriam R Anver; Robert H Shoemaker; Giovanni Melillo
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

7.  Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent Combretastatin-A4P (CA4P) on brain tumor xenografts.

Authors:  Li Liu; Ralph P Mason; Barjor Gimi
Journal:  Cancer Lett       Date:  2014-10-08       Impact factor: 8.679

Review 8.  Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors.

Authors:  Li Liu; Devin O'Kelly; Regan Schuetze; Graham Carlson; Heling Zhou; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

9.  A genetically encoded biosensor for visualising hypoxia responses in vivo.

Authors:  Tvisha Misra; Martin Baccino-Calace; Felix Meyenhofer; David Rodriguez-Crespo; Hatice Akarsu; Ricardo Armenta-Calderón; Thomas A Gorr; Christian Frei; Rafael Cantera; Boris Egger; Stefan Luschnig
Journal:  Biol Open       Date:  2017-02-15       Impact factor: 2.422

Review 10.  Detection of Hypoxia in Cancer Models: Significance, Challenges, and Advances.

Authors:  Inês Godet; Steven Doctorman; Fan Wu; Daniele M Gilkes
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.